Literature DB >> 22638964

Psychotropic medication claims among religious clergy.

Steven M Frenk1, Sarah A Mustillo, Steven L Foy, Whitney D Arroyave, Elizabeth G Hooten, Kari H Lauderback, Keith G Meador.   

Abstract

This study examined psychotropic medication claims in a sample of Protestant clergy. It estimated the proportion of clergy in the sample who had a claim for psychotropic medication (i.e., anti-depressants and anxiolytics) in 2005 and examined associations between sociodemographic characteristics, occupational distress and having a claim. Protestant clergy (n = 749) from nine denominations completed a mail survey and provided access to their pharmaceutical records. Logistic regression models assessed the effect of sociodemographic characteristics and occupational distress on having a claim. The descriptive analysis revealed that 16 % (95 % Confidence interval [CI] 13.3 %-18.5 %) of the clergy in the sample had a claim for psychotropic medication in 2005 and that, among clergy who experienced frequent occupational distress, 28 % (95 % CI 17.5 %-37.5 %) had a claim. The regression analysis found that older clergy, female clergy, and those who experienced frequent occupational distress were more likely to have a claim. Due to recent demographic changes in the clergy population, including the increasing mean age of new clergy and the growing number of female clergy, the proportion of clergy having claims for psychotropic medication may increase in the coming years. To the best of our knowledge, this is the first study to examine the use of psychotropic medication among clergy.

Mesh:

Substances:

Year:  2013        PMID: 22638964     DOI: 10.1007/s11126-012-9224-4

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  28 in total

1.  Influence of question structure on the recall of self-reported drug use.

Authors:  O H Klungel; A de Boer; A H Paes; R M Herings; J C Seidell; A Bakker
Journal:  J Clin Epidemiol       Date:  2000-03-01       Impact factor: 6.437

2.  Patterns of psychotropic medication use by race among veterans with bipolar disorder.

Authors:  Amy M Kilbourne; Harold Alan Pincus
Journal:  Psychiatr Serv       Date:  2006-01       Impact factor: 3.084

3.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  The effect of non-response on estimates of health care utilisation: linking health surveys and registers.

Authors:  Jens Gundgaard; Ola Ekholm; Ebba Holme Hansen; Niels Kr Rasmussen
Journal:  Eur J Public Health       Date:  2007-11-05       Impact factor: 3.367

5.  National estimates of antidepressant medication use among U.S. children, 1997-2002.

Authors:  Benedetto Vitiello; Samuel H Zuvekas; Grayson S Norquist
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-03       Impact factor: 8.829

6.  Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.

Authors:  Ilan Harpaz-Rotem; Robert A Rosenheck; Somaia Mohamed; Rani A Desai
Journal:  Psychiatr Serv       Date:  2008-10       Impact factor: 3.084

7.  For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.

Authors:  Tami L Mark
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

8.  Proportion of antidepressants prescribed without a psychiatric diagnosis is growing.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

9.  Use of benzodiazepine drugs and perceived job stress in a cohort of working men and women in Belgium. Results from the BELSTRESS-study.

Authors:  Edwin Pelfrene; Peter Vlerick; Michel Moreau; Rudolf P Mak; Marcel Kornitzer; Guy De Backer
Journal:  Soc Sci Med       Date:  2004-07       Impact factor: 4.634

10.  National patterns in antidepressant medication treatment.

Authors:  Mark Olfson; Steven C Marcus
Journal:  Arch Gen Psychiatry       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.